Search Results - "Mahdi, Jasia"
-
1
A Multispecialty Pediatric Neurovascular Conference: A Model for Interdisciplinary Management of Complex Disease
Published in Pediatric neurology (01-02-2015)“…Abstract Introduction In 2013, our institution established a multidisciplinary pediatric neurovascular conference for coordination of care. Here, we review our…”
Get full text
Journal Article -
2
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
Published in Nature (London) (31-03-2022)“…Diffuse intrinsic pontine glioma (DIPG) and other H3K27M-mutated diffuse midline gliomas (DMGs) are universally lethal paediatric tumours of the central…”
Get full text
Journal Article -
3
NCOG-46. CHROMOSOMAL LOSSES CORRELATE WITH POOR OVERALL SURVIVAL IN H3K27M-ALTERED DIFFUSE MIDLINE GLIOMAS
Published in Neuro-oncology (Charlottesville, Va.) (11-11-2024)“…Abstract BACKGROUND H3K27M-altered diffuse midline gliomas (DMG) have poor outcomes with limited biomarkers to predict overall survival. Stratification based…”
Get full text
Journal Article -
4
Tumor inflammation-associated neurotoxicity
Published in Nature medicine (01-04-2023)“…Cancer immunotherapies have unique toxicities. Establishment of grading scales and standardized grade-based treatment algorithms for toxicity syndromes can…”
Get full text
Journal Article -
5
Nonoptic pathway tumors in children with neurofibromatosis type 1
Published in Neurology (25-08-2020)“…OBJECTIVETo define the radiologic features and natural history of nonoptic pathway tumors (non-OPTs) in children with neurofibromatosis type 1 (NF1). METHODSWe…”
Get full text
Journal Article -
6
Pediatric Acute Stroke Protocol Activation in a Children’s Hospital Emergency Department
Published in Stroke (1970) (01-08-2015)“…BACKGROUND AND PURPOSE—Pediatric acute stroke teams are a new phenomenon. We sought to characterize the final diagnoses of children with brain attacks in the…”
Get full text
Journal Article -
7
A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1
Published in Neurology (18-04-2017)“…OBJECTIVE:To define the clinical and radiologic features of brainstem gliomas (BSGs) in children with neurofibromatosis type 1 (NF1). METHODS:We performed a…”
Get full text
Journal Article -
8
Stroke Mimics Are Not Benign in Immunocompromised Children
Published in Stroke (1970) (18-07-2022)Get full text
Journal Article -
9
IMMU-07. “STROKE MIMICS” ARE NOT BENIGN IN IMMUNOCOMPROMISED CHILDREN
Published in Neuro-oncology (Charlottesville, Va.) (01-06-2021)“…Abstract Objective To determine the clinical variances between strokes and stroke mimics in a pediatric immunocompromised population that consists of children…”
Get full text
Journal Article -
10
Stroke Mimics Are Not Benign in Immunocompromised Children
Published in Stroke (1970) (01-10-2022)Get full text
Journal Article -
11
IMMU-60. MYELOID POPULATIONS MODULATE GD2 CAR T CELL ACTIVITY IN DIFFUSE MIDLINE GLIOMA
Published in Neuro-oncology (Charlottesville, Va.) (11-11-2024)“…Abstract H3K27M-mutated diffuse midline gliomas (DMGs) are universally lethal cancers in children and young adults. Our team previously demonstrated efficacy…”
Get full text
Journal Article -
12
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas
Published in Nature (London) (13-11-2024)“…H3K27M-mutant diffuse midline gliomas (DMGs) express high levels of the disialoganglioside GD2 (ref. 1). Chimeric antigen receptor-modified T cells targeting…”
Get full text
Journal Article -
13
IMMU-05. TUMOR INFLAMMATION-ASSOCIATED NEUROTOXICITY (TIAN): A TOXICITY SYNDROME IN PATIENTS TREATED WITH IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM TUMORS
Published in Neuro-oncology (Charlottesville, Va.) (12-06-2023)“…Abstract Immunotherapies have transformed the therapeutic landscape for various cancer indications; currently several preclinical and clinical studies are…”
Get full text
Journal Article -
14
Abstract CT031: GD2 CAR T cells mediate clinical activity and manageable toxicity in children and young adults with DIPG and H3K27M-mutated diffuse midline gliomas
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract Background: Diffuse intrinsic pontine glioma (DIPG) and other H3K27M-mutated diffuse midline gliomas (DMGs) are universally lethal central nervous…”
Get full text
Journal Article -
15
DIPG-47. SEQUENTIAL INTRAVENOUS AND INTRACEREBROVENTRICULAR GD2-CAR T-CELL THERAPY FOR H3K27M-MUTATED DIFFUSE MIDLINE GLIOMAS
Published in Neuro-oncology (Charlottesville, Va.) (18-06-2024)Get full text
Journal Article -
16
DIPG-15. Major tumor regressions in H3K27M-mutated diffuse midline glioma (DMG) following sequential intravenous (IV) and intracerebroventricular (ICV) delivery of GD2-CAR T-cells
Published in Neuro-oncology (Charlottesville, Va.) (03-06-2022)“…Abstract BACKGROUND: H3K27M-mutated DMGs express high levels of the disialoganglioside GD2 and GD2-CAR T-cells (GD2-CART) regress DMG in preclinical models…”
Get full text
Journal Article -
17
Abstract T P360: Pediatric Acute Stroke Protocol Activation in a Children’s Hospital Emergency Department
Published in Stroke (1970) (01-02-2015)“…Abstract only Introduction: Many children’s hospitals, including ours, have instituted acute stroke protocols, with a pediatric acute stroke team that is…”
Get full text
Journal Article -
18
Increased prevalence of brain tumors classified as T2 hyperintensities in neurofibromatosis 1
Published in Neurology. Clinical practice (01-08-2018)“…We sought to define the radiologic features that differentiate neoplastic from non-neoplastic T2 hyperintensities (T2Hs) in neurofibromatosis type 1 (NF1) and…”
Get full text
Journal Article -
19
OMIC-11. SINGLE CELL RNA SEQUENCING FROM THE CSF OF SUBJECTS WITH H3K27M+ DIPG/DMG TREATED WITH GD2 CAR T-CELLULAR THERAPY
Published in Neuro-oncology (Charlottesville, Va.) (01-06-2021)“…Abstract Introduction We are conducting a Phase I clinical trial utilizing chimeric antigen receptor (CAR) T-cells targeting GD2 (NCT04196413) for…”
Get full text
Journal Article -
20
EPCT-14. GD2 CAR T-CELLS MEDIATE CLINICAL ACTIVITY AND MANAGEABLE TOXICITY IN CHILDREN AND YOUNG ADULTS WITH H3K27M-MUTATED DIPG AND SPINAL CORD DMG
Published in Neuro-oncology (Charlottesville, Va.) (01-06-2021)“…Abstract Background We previously discovered high expression of the disialoganglioside GD2 on H3K27M+ gliomas and demonstrated preclinical efficacy of…”
Get full text
Journal Article